Skip header and navigation

Refine By

3579 records – page 1 of 358.

7(th) Annual Symposium on Self-Monitoring of Blood Glucose (SMBG), May 8-10, 2014, Helsinki, Finland.

https://arctichealth.org/en/permalink/ahliterature264876
Source
Diabetes Technol Ther. 2014 Nov;16(11):794-815
Publication Type
Conference/Meeting Material
Article
Date
Nov-2014
Author
Christopher G Parkin
Anita Mlinac
Rolf Hinzmann
Source
Diabetes Technol Ther. 2014 Nov;16(11):794-815
Date
Nov-2014
Language
English
Publication Type
Conference/Meeting Material
Article
Keywords
Blood Glucose - metabolism
Blood Glucose Self-Monitoring - trends
Diabetes Mellitus - blood
Diabetes Mellitus, Type 1 - blood
Diabetes Mellitus, Type 2 - blood
Finland
Guidelines as Topic
Humans
Hypoglycemic Agents - administration & dosage
Insulin - administration & dosage
Monitoring, Ambulatory
Patient compliance
Abstract
International experts in the fields of diabetes, diabetes technology, endocrinology, mobile health, sport science, and regulatory issues gathered for the 7(th) Annual Symposium on Self-Monitoring of Blood Glucose (SMBG). The aim of this meeting was to facilitate new collaborations and research projects to improve the lives of people with diabetes. The 2014 meeting comprised a comprehensive scientific program, parallel interactive workshops, and two keynote lectures.
Notes
Cites: Diabet Med. 2011 Oct;28(10):1158-6721294770
Cites: Diabetes Care. 2012 Feb;35(2):204-1022210571
Cites: Diabetes Res Clin Pract. 2012 Oct;98(1):5-1022917639
Cites: J Diabetes Sci Technol. 2012 Sep;6(5):1060-7523063032
Cites: Pediatr Diabetes. 2012 Nov;13(7):545-5122776045
Cites: Diabetologia. 2013 Feb;56(2):284-9323093136
Cites: Diabetes Technol Ther. 2013 Feb;15(2):166-7123259764
Cites: J Diabetes Sci Technol. 2013;7(1):144-5223439170
Cites: J Diabetes Sci Technol. 2013;7(1):156-6223439172
Cites: N Engl J Med. 2013 Jul 18;369(3):224-3223789889
Cites: Pediatr Diabetes. 2013 Sep;14(6):422-822957743
Cites: Diabetes Care. 2013 Oct;36(10):2887-9423735724
Cites: Diabetes Care. 2013 Nov;36(11):3535-4223900589
Cites: BMC Pediatr. 2013;13:16324106787
Cites: Diabetes Metab. 2000 Apr;26(2):118-2410804326
Cites: N Engl J Med. 2001 May 3;344(18):1343-5011333990
Cites: Diabetes Care. 2001 Oct;24(10):1722-711574432
Cites: Mol Cell Endocrinol. 2001 Dec 20;185(1-2):93-811738798
Cites: Diabetologia. 2002 Mar;45(3):342-811914739
Cites: Diabet Med. 2002 Apr;19(4):265-7311942996
Cites: Diabetes. 2002 Jul;51(7):2321-412086968
Cites: Diabetes Care. 2003 Sep;26(9):2598-60312941725
Cites: J Consult Clin Psychol. 2004 Feb;72(1):31-4014756612
Cites: Prev Med. 2004 Jul;39(1):164-715207998
Cites: Lancet. 1989 Sep 9;2(8663):577-802570282
Cites: BMJ. 1991 Oct 26;303(6809):1019-221954451
Cites: Diabetes. 2011 May;60(5):1528-3421471513
Cites: Lancet. 2011 Jul 2;378(9785):49-5521722952
Cites: BMJ. 2011;343:d380521737469
Cites: Diabetes Care. 2011 Sep;34(9):1934-4221788632
Cites: Diabetes Care. 2011 Sep;34(9):2023-521868778
Cites: Int J Pharm Pract. 2011 Oct;19(5):342-921899614
Cites: PLoS One. 2011;6(8):e2407021904606
Cites: Diabetes Care. 2013 Dec;36(12):4160-224103902
Cites: Diabetes Care. 2013 Dec;36(12):4063-7024130355
Cites: J Diabetes Sci Technol. 2013 Nov;7(6):1585-9424351185
Cites: Clin Pharmacol Ther. 2014 Feb;95(2):147-5324060819
Cites: BMC Pregnancy Childbirth. 2014;14:7024524674
Cites: Acta Diabetol. 2014 Apr;51(2):205-1023681558
Cites: Diabetologia. 2014 Aug;57(8):1578-8524893863
Cites: Diabetes Care. 2011 Feb;34(2):262-721270183
Cites: Diabetes Care. 2011 Mar;34(3):574-921278138
Cites: Diabetes Care. 2014 Aug;37(8):2114-2224854041
Cites: Diabetes Res Clin Pract. 2013 Jul;101(1):57-6123726303
Cites: BMJ. 1994 May 21;308(6940):1323-88019217
Cites: Arch Dis Child. 1998 Feb;78(2):111-59579150
Cites: BMJ. 1999 Feb 13;318(7181):427-319974455
Cites: BMJ. 2006 Jul 8;333(7558):6516803942
Cites: Diabetes Care. 2006 Dec;29(12):2644-917130198
Cites: Diabetes Metab. 2007 Apr;33(2):158-6617300973
Cites: Pediatr Diabetes. 2008 Aug;9(4 Pt 2):360-618774996
Cites: N Engl J Med. 2008 Oct 2;359(14):1464-7618779236
Cites: Diabet Med. 2008 Sep;25(9):1036-4218937673
Cites: Ann Med. 2009;41(1):66-7218720095
Cites: Evid Rep Technol Assess (Full Rep). 2008 Nov;(175):1-142219408968
Cites: Pediatr Diabetes. 2009 Aug;10(5):298-30319175902
Cites: Diabetes Care. 2009 Dec;32(12):2245-5019767384
Cites: Diabetes Care. 2010 Jan;33(1):23-819837786
Cites: Diabetes Technol Ther. 2010 Mar;12(3):221-3120151773
Cites: Pediatr Diabetes. 2010 Feb;11(1):24-720015124
Cites: Pediatr Diabetes. 2010 Mar;11(2):116-2119566740
Cites: J Psychosom Res. 2010 Jun;68(6):539-4420488270
Cites: J Diabetes Sci Technol. 2010 May;4(3):562-7020513321
Cites: Gen Hosp Psychiatry. 2010 Jul-Aug;32(4):380-9520633742
Cites: N Engl J Med. 2010 Jul 22;363(4):311-2020587585
Cites: Diabetes Care. 2011 Jan;34(1):50-220929999
PubMed ID
25211215 View in PubMed
Less detail

A 12-year comparison of common therapeutic interventions in the burn unit.

https://arctichealth.org/en/permalink/ahliterature153001
Source
J Burn Care Res. 2009 Mar-Apr;30(2):281-7
Publication Type
Article
Author
Christopher Whitehead
Michael Serghiou
Author Affiliation
Department of Rehabilitation Services, Shriners Hospitals for Children, Galveston, Texas, USA.
Source
J Burn Care Res. 2009 Mar-Apr;30(2):281-7
Language
English
Publication Type
Article
Keywords
Burn Units - statistics & numerical data
Burns - rehabilitation
Canada
Disability Evaluation
Humans
Physical Therapy Modalities
Posture
Practice Guidelines as Topic
Questionnaires
Range of Motion, Articular
Skin Transplantation
Splints
United States
Abstract
Although most occupational and physical therapists in an acute burn care setting use similar therapy practices, the time frames at which these therapeutic interventions are carried out vary according to the burn centers' practices. The purpose of this survey was to investigate current trends in burn rehabilitation and compare the results with a similar survey performed in 1994. The survey was designed in a similar fashion to the 1994 survey to ascertain common trends in burn rehabilitation. The survey was sent to 100 randomly selected burn care facilities throughout the United States and Canada. Content included rehabilitation interventions, including evaluation, positioning, splinting, active range of motion, passive range of motion, ambulation, as well as the cross-training of therapists. Significant increases in the percentages of burn centers initiating common therapy practices were found. Positioning (41% increase), active range of motion (48% increase), passive range of motion (52% increase), and ambulation (29% increase) were all found to have increases in the number of burn centers employing these practices in the same time frame. Overall comparison from 1994 to 2006 shows that common therapy techniques are being initiated earlier in the patient's acute burn stay. These results are consistent with recent medical trends of earlier acute discharges and more focus on outpatient rehabilitation.
PubMed ID
19165113 View in PubMed
Less detail

100 years after Alzheimer: contemporary neurology practice assessment of referrals for dementia.

https://arctichealth.org/en/permalink/ahliterature153508
Source
Am J Alzheimers Dis Other Demen. 2008 Dec-2009 Jan;23(6):516-27
Publication Type
Article
Author
Tiffany W Chow
Carin Binder
Steven Smyth
Sharon Cohen
Alain Robillard
Author Affiliation
Department of Medicine, Division of Neurology, University of Toronto, Toronto, Ontario, Canada.
Source
Am J Alzheimers Dis Other Demen. 2008 Dec-2009 Jan;23(6):516-27
Language
English
Publication Type
Article
Keywords
Attitude of Health Personnel
Canada
Dementia - diagnosis - psychology - therapy
Humans
Neurology - methods - statistics & numerical data
Physician's Practice Patterns
Practice Guidelines as Topic
Primary Health Care - methods - statistics & numerical data
Psychiatric Status Rating Scales - statistics & numerical data
Questionnaires
Referral and Consultation - standards - statistics & numerical data
Abstract
The prevalence of dementia is placing an increased burden on specialists.
Canadian neurologists responded to a structured questionnaire to assess reasons for referral and services provided as well as to compare the neurologists' perceptions of their practice characteristics against cases seen over a 3-month period.
The audit confirmed the participants' perception that family practitioners are the main referral source (358/453, 79%). Sixty-two percent of patients had undergone clinical investigation for dementia prior to being seen by the neurologist; 39% (177/453) were on pharmacotherapy at the time of referral, 68% were initiated on pharmacotherapy by the neurologist. A fifth of the referrals did not meet clinical criteria for dementia, which may be directly related to the prevalence of prior workup that did not include mental status testing.
Neurologists currently treat patients referred for dementia who may already have been adequately evaluated and treated by primary care providers.
Notes
Comment In: Am J Alzheimers Dis Other Demen. 2008 Dec-2009 Jan;23(6):513-519222144
PubMed ID
19106275 View in PubMed
Less detail

The 1996 and 1997 National survey of physician asthma management practices: background and study methodology.

https://arctichealth.org/en/permalink/ahliterature201629
Source
Can Respir J. 1999 May-Jun;6(3):269-72
Publication Type
Article
Author
R L Jin
B C Choi
Author Affiliation
Laboratory Centre for Disease Control, Ottawa, Canada. robert_jin@hc-sc.gc.ca
Source
Can Respir J. 1999 May-Jun;6(3):269-72
Language
English
Publication Type
Article
Keywords
Adolescent
Analysis of Variance
Asthma - therapy
Attitude of Health Personnel
Canada
Child, Preschool
Confidence Intervals
Female
Health Care Surveys
Humans
Male
Physician's Practice Patterns - statistics & numerical data
Practice Guidelines as Topic - standards
Questionnaires
Abstract
To collect national baseline information on asthma management practices by physicians, and to compare these practices with the recommendations of the Canadian Asthma Consensus Conference ('the guidelines').
Cross-sectional survey of representative samples of physicians in Canada in late 1996 and early 1997.
Five specialty types of physicians who manage asthma patients: respirology, pediatrics, internal medicine, allergy and clinical immunology, and general practice and family medicine. Stratified sampling by province and specialty was used to select physicians for the study. Weighting was used in the analysis to generalize the results to the national level for the five specialty groups of physicians.
Mailed questionnaire, self-administered by the respondent; three mailings of the questionnaires were used to increase the response rate.
The frequency with which each of the five specialty types chose specific asthma management choices was determined, using weighted percentages representative of the specialty groups on a national basis. ANOVA determined the statistically significant differences among the five specialties in choosing particular asthma management actions. Then, logistic regression was used to calculate the odds ratios showing an association between the characteristics of the physician respondents and specific asthma management choices that they made in the survey.
The data analysis demonstrated significant variations among physicians in asthma management practices, according to specialty type and other characteristics. The initial report was released in April 1998, and manuscripts for journal submissions are being prepared.
PubMed ID
10393288 View in PubMed
Less detail

1998 revision of the Canadian Asthma Consensus Guidelines. Asthma Consensus Conference Editorial Committee.

https://arctichealth.org/en/permalink/ahliterature201632
Source
Can Respir J. 1999 May-Jun;6(3):231-2
Publication Type
Conference/Meeting Material
Article
Author
L P Boulet
A. Becker
D. Bérubé
P. Ernst
R. Beveridge
Author Affiliation
Institut de cardiologie et de pneumologie de l'Université Laval, Hôpital Laval, Sainte-Foy, Canada.
Source
Can Respir J. 1999 May-Jun;6(3):231-2
Language
English
Publication Type
Conference/Meeting Material
Article
Keywords
Asthma - therapy
Canada
Humans
Patient Care - standards
Practice Guidelines as Topic - standards
Societies, Medical
PubMed ID
10393284 View in PubMed
Less detail

The 2001 Canadian hypertension recommendations: take-home messages.

https://arctichealth.org/en/permalink/ahliterature188323
Source
CMAJ. 2002 Sep 17;167(6):661-8
Publication Type
Article
Date
Sep-17-2002
Author
Norman R C Campbell
Denis Drouin
Ross D Feldman
Author Affiliation
Department of Internal Medicine, Faculty of Medicine, University of Calgary, Alta. ncampbel@ucalgary.ca
Source
CMAJ. 2002 Sep 17;167(6):661-8
Date
Sep-17-2002
Language
English
Publication Type
Article
Keywords
Aged
Antihypertensive Agents - therapeutic use
Blood Chemical Analysis
Blood Pressure Determination
Canada
Female
Humans
Hypertension - diagnosis - drug therapy - therapy
Life Style
Practice Guidelines as Topic
Risk assessment
Notes
Cites: Hypertension. 2000 May;35(5):1025-3010818057
Cites: N Engl J Med. 2001 Jan 4;344(1):3-1011136953
Cites: Can J Cardiol. 2000 Sep;16(9):1094-10211021953
Cites: BMJ. 2001 Mar 3;322(7285):531-611230071
Cites: JAMA. 2001 May 16;285(19):2486-9711368702
Cites: Can J Cardiol. 2001 May;17(5):535-811381276
Cites: Can J Cardiol. 2001 May;17(5):543-5911381277
Cites: Can J Cardiol. 2001 Dec;17(12):1249-6311773936
Cites: Can J Cardiol. 2002 Jun;18(6):604-2412107419
Cites: Can J Cardiol. 2002 Jun;18(6):625-4112107420
Cites: CMAJ. 2002 Jun 25;166(13):1692-312126328
Cites: Am J Epidemiol. 1983 Apr;117(4):429-426837557
Cites: J Hypertens. 1992 Aug;10(8):887-961325524
Cites: Fam Pract. 1997 Apr;14(2):130-59137951
Cites: J Hypertens. 1999 Feb;17(2):151-8310067786
Cites: CMAJ. 1999 May 4;160(9):1341-310333841
Cites: CMAJ. 1999 May 4;160(9 Suppl):S21-810333850
Cites: CMAJ. 1999 Aug 10;161(3):277-810463050
Cites: J Hum Hypertens. 1999 Sep;13(9):569-9210482967
Cites: Circulation. 1999 Sep 28;100(13):1481-9210500053
Cites: CMAJ. 1999 Sep 21;161(6):699-70410513276
Cites: CMAJ. 1999;161 Suppl 12:S1-1710624417
Cites: BMJ. 2000 Mar 11;320(7236):686-9010710578
Cites: BMJ. 2000 Mar 11;320(7236):709-1010710588
Erratum In: CMAJ 2002 Oct 29;167(9):989
PubMed ID
12358202 View in PubMed
Less detail

2001 Canadian hypertension recommendations. What has changed?

https://arctichealth.org/en/permalink/ahliterature187643
Source
Can Fam Physician. 2002 Oct;48:1662-5
Publication Type
Article
Date
Oct-2002
Source
Can Fam Physician. 2002 Oct;48:1662-5
Date
Oct-2002
Language
English
Publication Type
Article
Keywords
Aged
Antihypertensive Agents - therapeutic use
Canada
Humans
Hypertension - drug therapy
Life Style
Middle Aged
Patient compliance
Practice Guidelines as Topic
Risk assessment
Notes
Cites: CMAJ. 1999;161 Suppl 12:S1-1710624417
Cites: BMJ. 2000 Mar 11;320(7236):709-1010710588
Cites: Circulation. 1999 Sep 28;100(13):1481-9210500053
Cites: Can J Cardiol. 2002 Jun;18(6):625-4112107420
Cites: Can J Cardiol. 2002 Jun;18(6):604-2412107419
Cites: Science. 1996 Nov 1;274(5288):740-38966556
Cites: Am J Hypertens. 1997 Oct;10(10 Pt 1):1097-1029370379
Cites: J Hum Hypertens. 1999 Sep;13(9):569-9210482967
Cites: Can J Cardiol. 2000 Sep;16(9):1094-10211021953
Cites: BMJ. 2001 Mar 3;322(7285):531-611230071
Cites: JAMA. 2001 May 16;285(19):2486-9711368702
Cites: Can J Cardiol. 2001 May;17(5):543-5911381277
Cites: Lancet. 2001 Sep 29;358(9287):1033-4111589932
Cites: Can J Cardiol. 2001 Dec;17(12):1249-6311773936
PubMed ID
12449551 View in PubMed
Less detail

The 2002 Canadian bone densitometry recommendations: take-home messages.

https://arctichealth.org/en/permalink/ahliterature187804
Source
CMAJ. 2002 Nov 12;167(10):1141-5
Publication Type
Article
Date
Nov-12-2002
Author
Aliya A Khan
Jacques P Brown
David L Kendler
William D Leslie
Brian C Lentle
E Michael Lewiecki
Paul D Miller
R Lawrence Nicholson
Wojciech P Olszynski
Nelson B Watts
Author Affiliation
Division of Geriatrics, McMaster University, Hamilton, ON. Avkhan@aol.com
Source
CMAJ. 2002 Nov 12;167(10):1141-5
Date
Nov-12-2002
Language
English
Publication Type
Article
Keywords
Bone Density
Canada
Female
Hip
Humans
Lumbar Vertebrae
Middle Aged
Osteoporosis, Postmenopausal - diagnosis
Practice Guidelines as Topic
Risk factors
Notes
Cites: Arch Intern Med. 1997 Dec 8-22;157(22):2609-159531230
Cites: Calcif Tissue Int. 1997 Dec;61(6):433-409383266
Cites: J Bone Miner Res. 1998 Oct;13(10):1587-939783547
Cites: Osteoporos Int. 1998;8 Suppl 4:S7-8010197173
Cites: JAMA. 1999 Aug 18;282(7):637-4510517716
Cites: Osteoporos Int. 1997;7 Suppl 3:S108-169536315
Cites: Osteoporos Int. 2000;11(3):192-20210824234
Cites: Am J Med. 2000 Sep;109(4):267-7610996576
Cites: J Bone Miner Res. 2000 Oct;15(10):1867-7011028437
Cites: Osteoporos Int. 2001;12(1):49-5411305083
Cites: Osteoporos Int. 2001;12(7):519-2811527048
Cites: J Clin Densitom. 2002 Fall;5(3):247-5712357062
Cites: CMAJ. 2002 Nov 12;167(10 Suppl):S1-3412427685
Cites: Ann Intern Med. 1991 Jun 1;114(11):919-232024857
Cites: J Bone Miner Res. 1992 Jun;7(6):639-461414482
Cites: Am J Epidemiol. 1993 May 1;137(9):1001-58317445
Cites: J Bone Miner Res. 1993 Oct;8(10):1227-338256660
Cites: J Bone Miner Res. 1994 Jun;9(6):951-608079669
Cites: World Health Organ Tech Rep Ser. 1994;843:1-1297941614
Cites: Osteoporos Int. 1994 Jul;4(4):226-97949753
Cites: N Engl J Med. 1995 Mar 23;332(12):767-737862179
Cites: J Orthop Res. 1995 Mar;13(2):250-77722762
Cites: Bone. 1995 Apr;16(4 Suppl):257S-262S7626313
Cites: Osteoporos Int. 1995;5(4):262-707492865
Cites: N Engl J Med. 1995 Nov 30;333(22):1437-437477143
Cites: BMJ. 1996 May 18;312(7041):1254-98634613
Cites: Bone. 1996 Mar;18(3 Suppl):197S-201S8777088
Cites: Lancet. 1996 Aug 24;348(9026):511-48757153
Cites: N Engl J Med. 1997 Sep 4;337(10):670-69278463
Comment In: CMAJ. 2003 Jan 21;168(2):14912538531
PubMed ID
12427706 View in PubMed
Less detail

2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada.

https://arctichealth.org/en/permalink/ahliterature187810
Source
CMAJ. 2002 Nov 12;167(10 Suppl):S1-34
Publication Type
Article
Date
Nov-12-2002
Author
Jacques P Brown
Robert G Josse
Author Affiliation
Division of Rheumatology, Centre de recherche du CHUL, Université Laval, Canada.
Source
CMAJ. 2002 Nov 12;167(10 Suppl):S1-34
Date
Nov-12-2002
Language
English
Publication Type
Article
Keywords
Adult
Aged
Bone Density
Canada
Child
Diet
Diphosphonates - therapeutic use
Estrogens, Non-Steroidal
Female
Humans
Isoflavones
Male
Middle Aged
Osteoporosis - diagnosis - drug therapy - prevention & control
Phytoestrogens
Plant Preparations
Practice Guidelines as Topic
Prognosis
Randomized Controlled Trials as Topic
Risk factors
Abstract
To revise and expand the 1996 Osteoporosis Society of Canada clinical practice guidelines for the management of osteoporosis, incorporating recent advances in diagnosis, prevention and management of osteoporosis, and to identify and assess the evidence supporting the recommendations.
All aspects of osteoporosis care and its fracture complications - including classification, diagnosis, management and methods for screening, as well as prevention and reducing fracture risk - were reviewed, revised as required and expressed as a set of recommendations.
Strategies for identifying and evaluating those at high risk; the use of bone mineral density and biochemical markers in diagnosis and assessing response to management; recommendations regarding nutrition and physical activity; and the selection of pharmacologic therapy for the prevention and management of osteoporosis in men and women and for osteoporosis resulting from glucocorticoid treatment.
All recommendations were developed using a justifiable and reproducible process involving an explicit method for the evaluation and citation of supporting evidence.
All recommendations were reviewed by members of the Scientific Advisory Council of the Osteoporosis Society of Canada, an expert steering committee and others, including family physicians, dietitians, therapists and representatives of various medical specialties involved in osteoporosis care (geriatric medicine, rheumatology, endocrinology, obstetrics and gynecology, nephrology, radiology) as well as methodologists from across Canada.
Earlier diagnosis and prevention of fractures should decrease the medical, social and economic burdens of this disease.
This document outlines detailed recommendations pertaining to all aspects of osteoporosis. Strategies for identifying those at increased risk (i.e., those with at least one major or 2 minor risk factors) and screening with central dual-energy x-ray absorptiometry at age 65 years are recommended. Bisphosphonates and raloxifene are first-line therapies in the prevention and treatment of postmenopausal osteoporosis. Estrogen and progestin/progesterone is a first-line therapy in the prevention and a second-line therapy in the treatment of postmenopausal osteoporosis. Nasal calcitonin is a second-line therapy in the treatment of postmenopausal osteoporosis. Although not yet approved for use in Canada, hPTH(1-34) is expected to be a first-line treatment for postmenopausal women with severe osteoporosis. Ipriflavone, vitamin K and fluoride are not recommended. Bisphosphonates are the first-line therapy for the prevention and treatment of osteoporosis in patients requiring prolonged glucocorticoid therapy and for men with osteoporosis. Nasal or parenteral calcitonin is a first-line treatment for pain associated with acute vertebral fractures. Impact-type exercise and age-appropriate calcium and vitamin D intake are recommended for the prevention of osteoporosis.
All recommendations were graded according to the strength of the evidence; where the evidence was insufficient and recommendations were based on consensus opinion alone, this is indicated. These guidelines are viewed as a work in progress and will be updated periodically in response to advances in this field.
Notes
Cites: J Clin Endocrinol Metab. 2000 May;85(5):1895-90010843171
Cites: Bone. 2000 Jul;27(1):123-810865219
Cites: J Bone Miner Res. 2000 Jul;15(7):1398-40410893690
Cites: Calcif Tissue Int. 2000 Jul;67(1):10-810908406
Cites: N Engl J Med. 2000 Aug 31;343(9):604-1010979796
Cites: Osteoporos Int. 2000;11(6):467-8010982161
Cites: J Clin Endocrinol Metab. 2000 Sep;85(9):3069-7610999788
Cites: Am J Med. 2000 Sep;109(4):267-7610996576
Cites: Calcif Tissue Int. 2000 Oct;67(4):277-8511000340
Cites: BMJ. 2000 Oct 21;321(7267):994-811039967
Cites: Spine (Phila Pa 1976). 1992 Mar;17(3):280-51566165
Cites: Calcif Tissue Int. 1992 Apr;50(4):381-31571851
Cites: Bone Miner. 1992 Feb;16(2):131-81576488
Cites: Ann Intern Med. 1992 Jul 1;117(1):1-91534476
Cites: J Nucl Med. 1992 Jun;33(6):1137-421597729
Cites: N Engl J Med. 1992 Jul 9;327(2):82-71603140
Cites: Calcif Tissue Int. 1991 Dec;49(6):369-721818759
Cites: J Bone Miner Res. 1992 Jul;7(7):761-91642145
Cites: BMJ. 1992 Sep 5;305(6853):556-611393035
Cites: J Appl Physiol (1985). 1992 Sep;73(3):1165-701400032
Cites: J Bone Miner Res. 1992 Sep;7(9):1005-101414493
Cites: Med Sci Sports Exerc. 1992 Nov;24(11):1190-41435170
Cites: N Engl J Med. 1992 Dec 3;327(23):1637-421331788
Cites: Maturitas. 1992 Dec;15(3):225-321465036
Cites: Lancet. 1993 Jan 9;341(8837):72-58093403
Cites: N Engl J Med. 1993 Feb 18;328(7):460-48421475
Cites: Osteoporos Int. 1993 Mar;3(2):71-58453193
Cites: Bone Miner. 1993 Feb;20(2):125-328453328
Cites: Calcif Tissue Int. 1993 Mar;52(3):212-58481835
Cites: Am J Med. 1993 Jun;94(6):646-508506892
Cites: Am J Epidemiol. 1993 May 1;137(9):1001-58317445
Cites: Br J Radiol. 1993 May;66(785):435-408319065
Cites: J Endocrinol Invest. 1993 May;16(5):333-78320424
Cites: Osteoporos Int. 1993 Jul;3(4):185-918338973
Cites: CMAJ. 1993 Aug 1;149(3):289-938339174
Cites: JAMA. 1993 Aug 18;270(7):841-48340983
Cites: J Clin Endocrinol Metab. 1993 Sep;77(3):770-58370698
Cites: Osteoporos Int. 1993 Sep;3(5):255-608400607
Cites: J Bone Miner Res. 1993 Aug;8(8):931-68213255
Cites: Calcif Tissue Int. 1999 Nov;65(5):359-6410541760
Cites: Osteoporos Int. 1999;9(4):296-30610550446
Cites: Osteoporos Int. 1999;9(4):358-6610550454
Cites: Osteoporos Int. 1999;9(5):461-810550467
Cites: Arthritis Rheum. 1999 Nov;42(11):2309-1810555025
Cites: J Bone Miner Res. 1999 Nov;14(11):1952-6210571696
Cites: J Am Geriatr Soc. 1999 Dec;47(12):1397-40210591231
Cites: Ann Intern Med. 1999 Dec 21;131(12):935-4210610644
Cites: Arterioscler Thromb Vasc Biol. 1999 Dec;19(12):2993-300010591680
Cites: Am J Clin Nutr. 2000 Jan;71(1):142-5110617959
Cites: Int J Clin Pract. 1998 Oct;52(7):453-510622084
Cites: Osteoporos Int. 1999;10(3):183-9210525709
Cites: J Clin Densitom. 2000 Spring;3(1):27-3310745299
Cites: J Bone Miner Res. 2000 Mar;15(3):515-2110750566
Cites: Ann Intern Med. 2000 May 2;132(9):689-9610787361
Cites: Am J Clin Nutr. 1986 Dec;44(6):863-763491533
Cites: Am J Clin Nutr. 1987 Aug;46(2):319-233618535
Cites: Eur J Clin Pharmacol. 1987;33(1):35-93319638
Cites: Lancet. 1987 Dec 26;2(8574):1481-32892047
Cites: Acta Paediatr Scand. 1988 Jan;77(1):89-933285637
Cites: Am J Clin Nutr. 1988 Sep;48(3 Suppl):842-93414592
Cites: J Bone Miner Res. 1986 Aug;1(4):377-813503551
Cites: Lancet. 1988 Nov 5;2(8619):1046-92903278
Cites: Bone Miner. 1988 Jul;4(3):265-773191284
Cites: BMJ. 1988 Dec 3;297(6661):1441-33147007
Cites: Age Ageing. 1988 Sep;17(5):319-273232586
Cites: BMJ. 1989 Jan 21;298(6667):147-512538173
Cites: Med Sci Sports Exerc. 1989 Feb;21(1):66-702927303
Cites: Br J Cancer. 1989 Mar;59(3):445-72930713
Cites: J Bone Miner Res. 1989 Apr;4(2):223-52728925
Cites: Clin Ther. 1989 Mar-Apr;11(2):205-92660996
Cites: Drugs Exp Clin Res. 1989;15(2):97-1042661184
Cites: Mayo Clin Proc. 1989 Jul;64(7):762-92671517
Cites: BMJ. 1989 Aug 19;299(6697):477-92507027
Cites: Eur J Appl Physiol Occup Physiol. 1993;67(4):330-48299600
Cites: Radiology. 1994 Mar;190(3):678-828115610
Cites: Osteoporos Int. 1994 Jan;4(1):1-58148565
Cites: J Bone Miner Res. 1994 Jan;9(1):69-738154311
Cites: Br J Rheumatol. 1994 Apr;33(4):348-508156307
Cites: BMJ. 1994 Apr 23;308(6936):1081-28173430
Cites: Minerva Endocrinol. 1993 Sep;18(3):115-218183178
Cites: Am J Respir Crit Care Med. 1994 Aug;150(2):394-78049820
Cites: Lancet. 1994 Aug 20;344(8921):543-47914635
Cites: Calcif Tissue Int. 1994 May;54(5):377-808062153
Cites: Osteoporos Int. 2000;11(7):556-6111069188
Cites: J Clin Densitom. 2000 Fall;3(3):269-8011090234
Cites: Osteoporos Int. 2000;11(8):709-1311095175
Cites: J Clin Endocrinol Metab. 2000 Nov;85(11):4118-2411095442
Cites: J Bone Miner Res. 2000 Dec;15(12):2309-1411127196
Cites: N Engl J Med. 2001 Feb 1;344(5):333-4011172164
Cites: Arthritis Rheum. 2001 Jan;44(1):202-1111212161
Cites: JAMA. 2001 Jan 17;285(3):320-311176842
Cites: J Orthop Sci. 2000;5(6):546-5111180916
Cites: Osteoporos Int. 2000;11(12):1018-2311256892
Cites: Osteoporos Int. 2000;11(12):1051-6211256897
Cites: JAMA. 2001 Mar 21;285(11):1482-811255425
Cites: Ann Intern Med. 1989 Oct 15;111(8):678-802679286
Cites: Arch Intern Med. 1989 Oct;149(10):2197-2002802886
Cites: Arch Intern Med. 1989 Nov;149(11):2445-82818106
Cites: Clin Endocrinol (Oxf). 1989 Apr;30(4):435-422688995
Cites: J Clin Endocrinol Metab. 1990 Jan;70(1):264-702294135
Cites: JAMA. 1990 Feb 2;263(5):665-82404146
Cites: N Engl J Med. 1990 Mar 22;322(12):802-92407957
Cites: Br J Ind Med. 1990 Jan;47(1):69-702310712
Cites: N Engl J Med. 1990 May 3;322(18):1265-712109197
Cites: N Engl J Med. 1990 Jul 12;323(2):73-92113611
Cites: Age Ageing. 1990 May;19(3):212-42363385
Cites: Am Rev Respir Dis. 1990 Jul;142(1):104-72195929
Cites: J Bone Miner Res. 2000 Apr;15(4):710-2010780863
Cites: J Bone Miner Res. 2000 Apr;15(4):721-3910780864
Cites: J Bone Miner Res. 2000 May;15(5):944-5110804025
Cites: CMAJ. 2000 May 2;162(9):1289-9410813010
Cites: Osteoporos Int. 2000;11(3):192-20210824234
Cites: J Bone Miner Res. 2000 Jun;15(6):993-100010841167
Cites: J Bone Miner Res. 2000 Jun;15(6):1006-1310841169
Cites: J Clin Endocrinol Metab. 2000 May;85(5):1783-810843152
Cites: Arch Intern Med. 1991 Oct;151(10):2026-321929691
Cites: Calcif Tissue Int. 1991;49 Suppl:S83-41834319
Cites: J Bone Miner Res. 1991 Nov;6(11):1227-331805545
Cites: J Bone Miner Res. 1995 Jun;10(6):940-77572318
Cites: Int J Epidemiol. 1995 Aug;24(4):771-828550275
Cites: J Bone Miner Res. 1995 Sep;10(9):1303-117502701
Cites: J Bone Miner Res. 1995 Sep;10(9):1312-207502702
Cites: Osteoporos Int. 1995;5(4):218-277492859
Cites: Osteoporos Int. 1995;5(4):262-707492865
Cites: Am J Clin Nutr. 1995 Oct;62(4):740-57572702
Cites: N Engl J Med. 1995 Nov 30;333(22):1437-437477143
Cites: J Bone Miner Res. 1995 Jul;10(7):1068-757484282
Cites: Bone. 1995 Oct;17(4):383-908573412
Cites: J Am Geriatr Soc. 1996 May;44(5):489-978617895
Cites: Calcif Tissue Int. 1996 Feb;58(2):73-808998681
Cites: BMJ. 1996 May 18;312(7041):1254-98634613
Cites: Osteoporos Int. 1995;5(6):462-68695969
Cites: Osteoporos Int. 1995;5(6):467-718695970
Cites: J Bone Miner Res. 1996 Apr;11(4):490-5018992880
Cites: J Am Geriatr Soc. 1996 Jul;44(7):756-628675921
Cites: Calcif Tissue Int. 1996 Jun;58(6):398-4018661479
Cites: Calcif Tissue Int. 1996 Jul;59(1):6-118661976
Cites: Osteoporos Int. 1996;6(2):171-78704358
Cites: Lancet. 1996 Jul 20;348(9021):145-98684153
Cites: Am J Epidemiol. 1996 Aug 1;144(3):255-638686694
Cites: Am J Obstet Gynecol. 1996 Jul;175(1):105-98694034
Cites: Biomed Pharmacother. 1995;49(10):465-88746073
Cites: Lancet. 1996 Aug 24;348(9026):511-48757153
Cites: N Engl J Med. 1996 Oct 3;335(14):1069-708801453
Cites: Bone. 1996 Jun;18(6):629-328806006
Cites: Miner Electrolyte Metab. 1996;22(4):207-138807623
Cites: Osteoporos Int. 1996;6(1):8-138845604
Cites: Med Sci Sports Exerc. 1993 Oct;25(10):1103-98231753
Cites: Am J Med. 1993 Dec;95(6):557-678259772
Cites: Calcif Tissue Int. 1993 Nov;53(5):307-118287317
Cites: Breast Cancer Res Treat. 2001 Jan;65(2):125-3411261828
Cites: BMJ. 2001 Mar 24;322(7288):697-70111264206
Cites: Osteoporos Int. 2001;12(2):85-9011303719
Cites: N Engl J Med. 2001 May 10;344(19):1434-4111346808
Cites: Climacteric. 2001 Mar;4(1):58-7411379379
Cites: JAMA. 2001 Jul 4;286(1):57-6311434827
Cites: NIH Consens Statement. 2000 Mar 27-29;17(1):1-4511525451
Cites: Calcif Tissue Int. 2001 Aug;69(2):73-711683426
Cites: Calcif Tissue Int. 2001 Oct;69(4):242-711730260
Cites: J Clin Densitom. 2001 Winter;4(4):363-7111748341
Cites: J Bone Miner Res. 2002 Jan;17(1):11-411771656
Cites: Eur J Clin Nutr. 2001 Dec;55(12):1091-711781676
Cites: J Orthop Sci. 2001;6(6):487-9211793169
Cites: Osteoporos Int. 2001 Dec;12(12):989-9511846333
Cites: JAMA. 2002 Feb 20;287(7):847-5711851576
Cites: Br J Sports Med. 2002 Feb;36(1):10-311867483
Cites: J Bone Miner Res. 2002 Mar;17(3):363-7211874228
Cites: J Bone Miner Res. 2002 May;17(5):834-4412009014
Cites: Arch Intern Med. 2002 May 27;162(10):1140-312020184
Cites: J Bone Miner Res. 2002 Jun;17(6):1051-612054160
Cites: CMAJ. 2002 May 28;166(11):1426-3012054412
Cites: Osteoporos Int. 1999;10(3):214-2110525713
Cites: Osteoporos Int. 2000;11(1):83-9110663363
Cites: J Clin Endocrinol Metab. 2000 Feb;85(2):720-610690882
Cites: Br J Sports Med. 2000 Feb;34(1):18-2210690445
Cites: Semin Arthritis Rheum. 2000 Feb;29(4):228-5110707991
Cites: BMJ. 2000 Mar 18;320(7237):754-810720360
Cites: Arch Intern Med. 2000 Mar 13;160(5):705-810724057
Cites: Aging (Milano). 2000 Feb;12(1):1-1210746426
Cites: Epidemiol Rev. 1985;7:178-2083902494
Cites: Am J Clin Nutr. 1985 Nov;42(5):877-883877451
Cites: Acta Obstet Gynecol Scand. 1986;65(3):211-73739627
Cites: Calcif Tissue Int. 1997 Jul;61(1):39-439192511
Cites: J Bone Miner Res. 1997 Jul;12(7):1075-829200007
Cites: Am J Med. 1997 Jan;102(1):29-379209198
Cites: Ann Rheum Dis. 1997 Jun;56(6):357-639227164
Cites: N Engl J Med. 1997 Aug 7;337(6):382-79241127
Cites: Calcif Tissue Int. 1997 Aug;61(2):142-79236262
Cites: N Engl J Med. 1997 Aug 21;337(8):523-89262495
Cites: N Engl J Med. 1997 Sep 4;337(10):670-69278463
Cites: Age Ageing. 1997 Jul;26(4):253-609271287
Cites: Am J Med. 1997 Aug;103(2):92-99274891
Cites: BMJ. 1997 Aug 2;315(7103):305-89274555
Cites: J Clin Endocrinol Metab. 1997 Sep;82(9):2784-919284696
Cites: Lancet. 1997 Aug 23;350(9077):550-59284777
Cites: J Bone Miner Res. 1997 Sep;12(9):1453-629286762
Cites: J Bone Miner Res. 1997 Sep;12(9):1463-709286763
Cites: Br J Nutr. 1997 Jul;78(1):65-729292760
Cites: Am J Clin Nutr. 1997 Oct;66(4):867-739322562
Cites: Age Ageing. 1997 Sep;26(5):359-659351480
Cites: BMJ. 1997 Oct 25;315(7115):1065-99366737
Cites: Calcif Tissue Int. 1997 Nov;61(5):382-59351879
Cites: N Engl J Med. 1997 Dec 4;337(23):1641-79385122
Cites: CMAJ. 1997 Nov 15;157(10):1357-639371065
Cites: Osteoporos Int. 1997;7(4):331-79373566
Cites: J Bone Miner Res. 1997 Nov;12(11):1761-89383679
Cites: Acta Orthop Scand Suppl. 1997 Oct;275:108-119385282
Cites: Acta Orthop Scand Suppl. 1997 Oct;275:112-49385283
Cites: Maturitas. 1997 Sep;28(1):75-819391998
Cites: Proc Natl Acad Sci U S A. 1997 Dec 9;94(25):14105-109391160
Cites: Osteoporos Int. 1997;7(5):488-959425508
Cites: Bone. 1994 May-Jun;15(3):279-848068448
Cites: N Engl J Med. 1994 Sep 29;331(13):821-78078528
Cites: J Bone Miner Res. 1994 Jun;9(6):951-608079669
Cites: Agents Actions. 1994 Mar;41(1-2):86-78079827
Cites: Calcif Tissue Int. 1994 Jun;54(6):477-808082050
Cites: World Health Organ Tech Rep Ser. 1994;843:1-1297941614
Cites: Am J Clin Nutr. 1994 Nov;60(5):744-507619105
Cites: Calcif Tissue Int. 1994 Aug;55(2):82-67953984
Cites: J Clin Endocrinol Metab. 1994 Oct;79(4):950-47962303
Cites: J Bone Miner Res. 1994 Aug;9(8):1137-417976495
Cites: Eur J Clin Invest. 1994 Aug;24(8):565-97982445
Cites: JAMA. 1994 Dec 28;272(24):1909-147990242
Cites: Osteoporos Int. 1994 Sep;4(5):245-527812072
Cites: J Bone Miner Res. 1994 Oct;9(10):1503-147817795
Cites: J Bone Miner Res. 1994 Oct;9(10):1591-57817805
Cites: Thorax. 1994 Nov;49(11):1099-1027831624
Cites: N Engl J Med. 1995 Mar 23;332(12):767-737862179
Cites: J Gerontol A Biol Sci Med Sci. 1995 Mar;50(2):B97-1047874586
Cites: Fertil Steril. 1995 Apr;63(4):747-557890057
Cites: J Pediatr. 1995 Apr;126(4):551-67699532
Cites: Osteoporos Int. 1995 Jan;5(1):39-467703623
Cites: Am J Med. 1995 Apr;98(4):331-57709944
Cites: Am J Med. 1995 May;98(5):452-87733123
Cites: Calcif Tissue Int. 1995 Mar;56(3):181-57750020
Cites: N Engl J Med. 1990 Sep 27;323(13):878-832203964
Cites: Am J Epidemiol. 1990 Oct;132(4):675-842403108
Cites: Bone. 1990;11(4):229-322242288
Cites: Ann Intern Med. 1991 Jun 1;114(11):919-232024857
Cites: Calcif Tissue Int. 1991 May;48(5):302-72054714
Cites: Am J Clin Nutr. 1991 Jul;54(1):157-632058578
Cites: Ann Intern Med. 1991 Oct 1;115(7):505-121883119
Cites: J Bone Miner Res. 1991 Jun;6(6):583-901887821
Cites: Ann Intern Med. 1995 Sep 15;123(6):401-87639438
Cites: Am J Med. 1995 Sep;99(3):235-427653482
Cites: Br J Nutr. 1995 Jul;74(1):125-397547823
Cites: Transplantation. 1998 Oct 27;66(8):1004-89808483
Cites: CMAJ. 1998;159 Suppl 8:S1-299834731
Cites: Radiol Technol. 1998 Nov-Dec;70(2):224, 2239839336
Cites: J Bone Miner Res. 1998 Dec;13(12):1814-219844098
Cites: J Bone Miner Res. 1998 Dec;13(12):1915-239844110
Cites: J Bone Miner Res. 1998 Dec;13(12):1932-99844112
Cites: JAMA. 1998 Dec 23-30;280(24):2077-829875874
Cites: J Bone Miner Res. 1999 Jan;14(1):90-1019893070
Cites: Calcif Tissue Int. 1999 Feb;64(2):179-839914328
Cites: Am J Clin Nutr. 1999 Jan;69(1):74-99925126
Cites: Am J Clin Nutr. 1999 Jan;69(1):147-529925137
Cites: Lancet. 1999 Jan 9;353(9147):93-710023893
Cites: Calcif Tissue Int. 1999 Mar;64(3):200-410024375
Cites: Osteoporos Int. 1998;8(4):333-4010024903
Cites: Ann Rheum Dis. 1998 Dec;57(12):724-710070271
Cites: Bone. 1999 Mar;24(3):261-410071920
Cites: Lancet. 1999 Mar 13;353(9156):878-8210093980
Cites: Osteoporos Int. 1998;8 Suppl 4:S7-8010197173
Cites: Obstet Gynecol. 1999 Apr;93(4):558-6510214833
Cites: Maturitas. 1999 Jan 4;31(2):161-410227010
Cites: J Bone Miner Res. 1999 May;14(5):821-810320531
Cites: Osteoporos Int. 1998;8(6):563-910326062
Cites: Med Sci Sports Exerc. 1999 May;31(5):646-5210331882
Cites: Rev Rhum Engl Ed. 1999 Apr;66(4):214-910339777
Cites: Calcif Tissue Int. 1999 Jun;64(6):490-810341021
Cites: Osteoporos Int. 1999;9(1):1-1210367023
Cites: Osteoporos Int. 1999;9(2):188-9210367048
Cites: Ann Intern Med. 1999 Jun 1;130(11):897-90410375338
Cites: JAMA. 1999 Jun 16;281(23):2189-9710376571
Cites: J Bone Miner Res. 1996 Feb;11(2):218-258822346
Cites: J Bone Miner Res. 1996 Feb;11(2):293-78822354
Cites: Bone. 1996 Feb;18(2):141-508833208
Cites: Bone. 1996 Feb;18(2):207-128833216
Cites: CMAJ. 1996 Oct 1;155(7):921-38837540
Cites: J Bone Miner Res. 1996 Mar;11(3):337-498852944
Cites: CMAJ. 1996 Oct 15;155(8):1113-338873639
Cites: Osteoporos Int. 1996;6(4):276-838883115
Cites: Osteoporos Int. 1996;6(4):303-78883119
Cites: Osteoporos Int. 1996;6(4):308-138883120
Cites: J Bone Miner Res. 1996 Oct;11(10):1531-88889854
Cites: JAMA. 1996 Nov 6;276(17):1389-968892713
Cites: Med Sci Sports Exerc. 1996 Oct;28(10):1243-68897380
Cites: J Gerontol A Biol Sci Med Sci. 1996 Nov;51(6):B425-338914492
Cites: J Rheumatol. 1996 Nov;23(11):1875-98923359
Cites: Osteoporos Int. 1996;6(5):399-4068931035
Cites: Am J Med. 1996 Nov;101(5):488-5018948272
Cites: Lancet. 1996 Dec 7;348(9041):1535-418950879
Cites: J Bone Miner Res. 1996 Dec;11(12):1961-68970899
Cites: Can J Physiol Pharmacol. 1996 Oct;74(10):1180-59022839
Cites: J Clin Endocrinol Metab. 1997 Feb;82(2):620-89024265
Cites: Osteoporos Int. 1996;6(6):437-419116388
Cites: Clin Sci (Lond). 1997 Jan;92(1):75-809038595
Cites: J Hepatol. 1997 Feb;26(2):325-309059953
Cites: Mayo Clin Proc. 2002 Jul;77(7):629-3712108600
Cites: JAMA. 2002 Jul 17;288(3):321-3312117397
Cites: Calcif Tissue Int. 2002 Aug;71(2):103-1112085156
Cites: J Lab Clin Med. 1971 Dec;78(6):994-55131875
Cites: Br Med J. 1980 Jun 7;280(6228):1340-46992932
Cites: J Clin Endocrinol Metab. 1981 Apr;52(4):751-86970749
Cites: Lancet. 1984 Aug 4;2(8397):2836146829
Cites: South Med J. 1984 Dec;77(12):1509-156505760
Cites: Osteoporos Int. 1997;7(2):126-329166392
Cites: J Clin Endocrinol Metab. 1997 Jun;82(6):1904-109177404
Cites: Calcif Tissue Int. 1997 Jul;61(1):10-59192504
Cites: Ann Intern Med. 1998 Feb 15;128(4):253-619471927
Cites: N Engl J Med. 1998 Feb 19;338(8):485-929443925
Cites: Bone. 1998 Feb;22(2):147-519477238
Cites: J Bone Miner Res. 1998 Feb;13(2):168-749495509
Cites: J Bone Miner Res. 1998 Feb;13(2):303-99495525
Cites: Maturitas. 1997 Dec 15;28(2):147-519522322
Cites: J Bone Miner Res. 1998 Mar;13(3):483-909525349
Cites: J Clin Endocrinol Metab. 1998 Apr;83(4):1128-339543129
Cites: Am J Med. 1998 Mar;104(3):219-269552083
Cites: Calcif Tissue Int. 1998 Jun;62(6):491-69576975
Cites: JAMA. 1998 May 13;279(18):1445-519600478
Cites: Osteoporos Int. 1997;7(6):575-829604055
Cites: J Bone Miner Res. 1998 Jun;13(6):918-249626622
Cites: Ann Intern Med. 1998 Jul 1;129(1):1-89652994
Cites: J Bone Miner Res. 1998 Jul;13(7):1141-89661078
Cites: J Bone Miner Res. 1998 Jul;13(7):1149-579661079
Cites: J Clin Endocrinol Metab. 1998 Jul;83(7):2266-749661593
Cites: Clin Endocrinol (Oxf). 1998 May;48(5):655-629666879
Cites: Osteoporos Int. 1998;8(2):152-89666939
Cites: N Engl J Med. 1998 Jul 30;339(5):292-99682041
Cites: Menopause. 1998 Spring;5(1):9-159689189
Cites: Osteoporos Int. 1998;8(1):4-129692071
Cites: Osteoporos Int. 1998;8(1):47-529692077
Cites: Endocr J. 1998 Apr;45(2):191-2019700472
Cites: Thorax. 1998 May;53(5):351-69708225
Cites: Endocr Rev. 1998 Aug;19(4):397-4289715373
Cites: JAMA. 1998 Aug 19;280(7):605-139718051
Cites: JAMA. 1998 Aug 19;280(7):650-29718060
Cites: Int J Gynaecol Obstet. 1998 Jul;62(1):69-759722129
Cites: J Bone Miner Res. 1998 Sep;13(9):1431-89738515
Cites: J Natl Cancer Inst. 1998 Sep 16;90(18):1371-889747868
Cites: Am J Clin Nutr. 1998 Oct;68(4):854-89771862
Cites: J Bone Miner Res. 1998 Oct;13(10):1587-939783547
Cites: J Clin Invest. 1998 Oct 15;102(8):1627-339788977
Cites: Osteoporos Int. 1998;8(3):255-609797910
Cites: Scand J Rheumatol. 1999;28(3):152-610380836
Cites: Clin Chem. 1999 Jul;45(7):1009-1710388477
Cites: J Clin Endocrinol Metab. 1999 Jul;84(7):2349-5210404801
Cites: J Am Geriatr Soc. 1999 Jul;47(7):850-310404930
Cites: Bone. 1999 Jul;25(1):97-10610423031
Cites: J Clin Endocrinol Metab. 1999 Aug;84(8):2700-410443663
Cites: J Bone Miner Res. 1999 Aug;14(8):1387-9310457271
Cites: J Bone Miner Res. 1999 Aug;14(8):1449-5610457279
Cites: J Bone Miner Res. 1999 Sep;14(9):1614-2110469291
Cites: Obstet Gynecol. 1999 Sep;94(3):330-610472854
Cites: Horm Res. 1999;51(4):178-8310474019
Cites: Cancer Causes Control. 1999 Aug;10(4):253-6010482483
Cites: J Clin Endocrinol Metab. 1999 Sep;84(9):3076-8110487668
Cites: Menopause. 1999 Fall;6(3):233-4110486794
Cites: J Bone Miner Res. 1999 Oct;14(10):1672-910491214
Cites: JAMA. 1999 Aug 18;282(7):637-4510517716
Cites: JAMA. 1999 Oct 13;282(14):1344-5210527181
Cites: J Clin Invest. 1964 Apr;43:545-5514149908
Cites: Int J Gynaecol Obstet. 1995 Mar;48(3):283-87781871
Cites: Bone. 1995 Mar;16(3):325-327786635
Cites: Calcif Tissue Int. 1995 Jan;56(1):38-417796344
Cites: Am J Clin Nutr. 1995 Jul;62(1):58-677598067
Cites: Am J Med. 1995 Jul;99(1):36-427598140
Cites: Bone. 1995 Apr;16(4):469-767605708
Cites: J Bone Miner Res. 1995 Apr;10(4):586-937610929
Cites: Am J Med. 1995 Aug;99(2):144-527625419
Cites: J Clin Oncol. 1997 Mar;15(3):955-629060533
Cites: Ann Med. 1997 Feb;29(1):55-629073324
Cites: Osteoporos Int. 1997;7(1):29-359102059
Cites: J Clin Invest. 1997 Mar 15;99(6):1287-949077538
Cites: Arch Intern Med. 1997 Mar 24;157(6):629-349080917
Cites: J Bone Miner Res. 1997 Apr;12(4):509-219101362
Cites: Br J Rheumatol. 1997 Feb;36(2):255-99133941
Cites: Osteoporos Int. 1997;7(2):119-259166391
Comment In: CMAJ. 2007 Oct 23;177(9):1069; author reply 1069-7017954901
Comment In: CMAJ. 2003 Jun 24;168(13):1644-5; author reply 1645-612821610
Comment In: CMAJ. 2003 Mar 18;168(6):675-6; author reply 67612642419
Comment In: CMAJ. 2003 Mar 18;168(6):67212642415
Comment In: CMAJ. 2003 Jun 24;168(13):1644; author reply 1645-612821611
Erratum In: CMAJ. 2003 Mar 18;168(6):676.
Erratum In: CMAJ. 2003 Mar 4;168(5):544
Erratum In: CMAJ. 2003 Feb 18;168(4):400
PubMed ID
12427685 View in PubMed
Less detail

The 2003 Canadian recommendations for dyslipidemia management: revisions are needed.

https://arctichealth.org/en/permalink/ahliterature175311
Source
CMAJ. 2005 Apr 12;172(8):1027-31
Publication Type
Article
Date
Apr-12-2005
Author
Douglas G Manuel
Peter Tanuseputro
Cameron A Mustard
Susan E Schultz
Geoffrey M Anderson
Sten Ardal
David A Alter
Andreas Laupacis
Author Affiliation
Institute for Clinical Evaluative Sciences, Toronto, Ont. doug.manuel@ices.on.ca
Source
CMAJ. 2005 Apr 12;172(8):1027-31
Date
Apr-12-2005
Language
English
Publication Type
Article
Keywords
Adolescent
Adult
Aged
Canada
Cholesterol, LDL - blood
Coronary Disease - mortality - prevention & control
Cost-Benefit Analysis
Health Expenditures
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use
Hyperlipidemias - drug therapy
Hypolipidemic Agents - therapeutic use
Middle Aged
Practice Guidelines as Topic
Risk factors
Notes
Cites: Eur Heart J. 2003 Sep;24(17):1601-1012964575
Cites: CMAJ. 2003 Jun 24;168(13):1644-5; author reply 1645-612821610
Cites: Can J Cardiol. 2003 Nov;19(12):1359-6614631469
Cites: Can J Cardiol. 2003 Dec;19(13):1499-50214760440
Cites: Am J Med. 2004 Apr 15;116(8):540-515063816
Cites: JAMA. 2004 Apr 21;291(15):1864-7015100205
Cites: Am Heart J. 1991 Jan;121(1 Pt 2):293-81985385
Cites: N Engl J Med. 1998 Nov 5;339(19):1349-579841303
Cites: Can J Cardiol. 1999 Apr;15(4):445-5110322254
Cites: CMAJ. 2003 Oct 28;169(9):921-414581310
Cites: Fam Pract. 2003 Feb;20(1):16-2112509365
Cites: JAMA. 2002 Jul 24-31;288(4):462-712132976
Cites: JAMA. 2002 Jul 24-31;288(4):455-6112132975
Cites: JAMA. 1999 Dec 22-29;282(24):2340-610612322
Cites: CMAJ. 2000 May 16;162(10):1441-710834048
Cites: CMAJ. 2000 Aug 22;163(4):403-810976255
Cites: Lancet. 2002 Jul 6;360(9326):7-2212114036
Comment In: CMAJ. 2005 Nov 8;173(10):1210; author reply 121016275979
Comment In: CMAJ. 2005 Nov 8;173(10):1207; author reply 121016275976
Comment In: CMAJ. 2005 Apr 12;172(8):1033-4; discussion 103715824410
Erratum In: CMAJ. 2005 Jul 19;173(2):133
PubMed ID
15824409 View in PubMed
Less detail

3579 records – page 1 of 358.